Trial Profile
Effect of ARN-6039 for the treatment of psoriasis.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs SLX 0528 (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 09 Jun 2016 New trial record